ENDO INTERNATIONAL PLC (ENDP) Stock News

USA - NASDAQ:ENDP - IE00BJ3V9050 - Common Stock

0.2926 USD

-0.02 (-5%)

Last: 8/25/2022, 10:28:44 PM

0.26 USD

-0.03 (-11.14%)

After Hours: 8/25/2022, 10:28:44 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ENDP Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: C3i Laboratoires

News Image

C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

3 years ago - By: Benzinga - Mentions: TEVA CVS JNJ ABBV ...

Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery

3 years ago - By: Benzinga - Mentions: GLS RGLS NERV TALK ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

3 years ago - By: InvestorPlace - Mentions: TJX MANU

TJX Companies (TJX) Stock Moves on Mixed Q2 Earnings

3 years ago - By: InvestorPlace - Mentions: DRLL

What Is Going on With Endo International (ENDP) Stock Today?

3 years ago - By: InvestorPlace

Endo International (ENDP) Stock Plunges Amid Bankruptcy Warning

3 years ago - By: Endo International plc

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

3 years ago - By: InvestorPlace - Mentions: HIL BBIG BBBY QNRX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: Bloomberg

Drugmaker Endo Files for Bankrupty Over Debt, US Opioid Litigation

3 years ago - By: Endo International plc

Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation

3 years ago - By: Bloomberg - Mentions: BABA

Endo Creditors Eye Plan for Drugmaker’s Sale Through Bankruptcy

3 years ago - By: BusinessInsider

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

3 years ago - By: SK Biopharmaceuticals

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel